To the Editor: Taylor and colleagues1 suggest lowering the National Health and Medical Research Council intervention level for blood lead level (BLL) because two reports indicate that health effects occur at lower BLLs.2,3 Such action may be unwarranted as these effects could be artefacts of suspect methodology that was missed by peer reviewers.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
No relevant disclosures.